Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years

Name: Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years
License: Public Domain

GlaxoSmithKline

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

influenza

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 256953
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.